Carlos Cruchaga, Ph.D., is a human genomicist with expertise in multiomics, informatics, and neurodegeneration. He completed his Ph.D. in Biochemistry and Molecular Biology in 2005 at University of Navarra in Spain. During his first post-doctoral he conducted statistical human genetics studies focused on Alzheimer’s disease and Parkinson’s disease, completing his training in quantitative human genomics.
Dr. Cruchaga established his laboratory at Washington University in 2011, studying the genetic architecture of neurodegenerative diseases.
His interests are focused in using human genomic and other omic data (proteomic, metabolomics, lipidomics) and AI/ML to identify and understand the biological process leading to Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and other neurodegenerative processes, with the ultimate goal of identifying novel biomarkers and prediction models as well as to identify novel targets and interventions.
In 2019, he became the leader of the NeuroGenomics and Informatics group at Washington University.